Abstract

BackgroundTo compare the incidence of osteoporotic fractures in patients with rheumatoid arthritis (RA) with matched controls from a university hospital.MethodsConsecutive RA patients (n = 100) were matched (age and sex) with controls (1:2). The follow-up period began at the index date, defined as the date of diagnosis for RA patients and the date of the first medical claim at the Health Management Organization (HMO) for non-RA patients. Fracture incidence rates per 1000 persons-years (PY) for distinct types of fractures were calculated. Multivariate cox regression analysis was performed to identify factors associated with fractures.ResultsOne hundred RA patients were followed for a total of 975.1 patients-years and 200 controls for 1485.7 patients-years. No difference was found in the overall fracture incidence rate per 1000 PY between RA and controls (19.5, 95% CI 12.7–28.6 vs 12.1, 95% CI 7.7–18.7, p = 0.07). In the Cox regression analysis, only age (HR 1.06, 95% CI 1.02–1.11, p = 0.006) and history of a prior fracture (HR 9.85, 95% CI 2.97–32.64, p < 0.001) were associated with fractures after the index date. The stratified analysis of the fractures by location showed that only the vertebral fractures were more frequent in RA patients compared with controls (12.9 per 1000 PY, 95% CI 8.9–25.8, vs. 3.4, 95% CI 1.4–8.1, respectively, p = 0.01).ConclusionPatients with RA didn’t show an overall increased risk of osteoporotic fractures compared with matched controls, but vertebral fractures were more frequently observed in patients with RA.

Highlights

  • Osteoporosis (OP) is a systemic skeletal disease characterized by decreased bone strength with a consequent increase in bone fragility and susceptibility to fracture due to low bone mass and microarchitecture alterations that generate a reduction of bone resistance to torsion and compression [1,2,3]

  • Regarding the rheumatoid arthritis (RA) patients, 97.9% were seropositive for Rheumatoid Factor and/or Anti Citrullinated Peptide Antibodies (ACPA), 94% were treated with conventional DiseaseModifying Antirheumatic Drugs (DMARDs), and 20% with biologic DMARDs

  • When analyzing each type of fracture, only the vertebral fractures were more frequently found in RA patients compared with controls (12.9 per 1000 PY, 95% confidence intervals (95% CI) 8.9– 25.8, versus 3.4, 95% CI 1.4–8.1, p = 0.01, respectively) (Table 2)

Read more

Summary

Introduction

Osteoporosis (OP) is a systemic skeletal disease characterized by decreased bone strength with a consequent increase in bone fragility and susceptibility to fracture due to low bone mass and microarchitecture alterations that generate a reduction of bone resistance to torsion and compression [1,2,3]. These fractures, known as fragility fractures, are bone cracks caused by a low-energy trauma (i.e. falling from a standing height) that should not be able to break a healthy bone [4]. To compare the incidence of osteoporotic fractures in patients with rheumatoid arthritis (RA) with matched controls from a university hospital

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call